A novel intracellular antigen in HL-60 cells that changes in molecular weight after granulocytic and monocytic

Y Katsura1, S Shimomura, O Takatani

  • 13rd Department of Internal Medicine, National Defense Medical College, Tokyo, Japan.

Leukemia Research
|September 1, 1995
PubMed

Insights

Researchers identified a novel antigen crucial for cell differentiation. This 100,000 M(r) antigen (p100) shifts to a 95,000 M(r) form (p95) during granulocytic or monocytic differentiation in HL-60 cells.

Area of Science:

  • Cell Biology
  • Immunology
  • Molecular Biology

Background:

  • Cell differentiation is a fundamental biological process.
  • Understanding molecular markers of differentiation is key.
  • HL-60 cells are a promyelocytic leukemia cell line widely used in differentiation studies.

Purpose of the Study:

  • To identify and partially characterize a novel antigen involved in cellular differentiation.
  • To investigate the molecular changes of this antigen during HL-60 cell differentiation.

Main Methods:

  • Production of a monoclonal antibody (D29A8) against HL-60 cell nuclei.
  • Immunization of BALB/c mice with HL-60 cell nuclei.
  • Western blot analysis to detect antigen molecular weight.
  • Induction of HL-60 cell differentiation along granulocytic and monocytic pathways.

Main Results:

  • A novel antigen with a molecular weight of 100,000 (p100) was identified using monoclonal antibody D29A8.
  • The antibody primarily detected p100 in the nucleolus of undifferentiated HL-60 cells.
  • Upon differentiation into granulocytic or monocytic lineages, the antibody detected a 95,000 molecular weight form (p95) predominantly in the cytoplasm.

Conclusions:

  • The identified antigen exists in at least two subtypes (p100 and p95) associated with different cellular differentiation stages.
  • These antigen subtypes appear to play a significant role in the process of cellular differentiation.
  • Further research into this antigen could elucidate mechanisms of cell fate determination.

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...